Polatuzumab vedotin Antibody
Polatuzumab vedotin is an antibody-drug conjugate (ADC) comprising an anti-CD79b monoclonal antibody linked to the cytotoxic agent monomethyl auristatin E (MMAE) . It is a research tool for studying large B-cell lymphomas (LBCL), with applications in both in vitro cytotoxicity assays and in vivo xenograft models to investigate its mechanism and therapeutic potential.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs)
Clonality
Monoclonal
Conjugation
Unconjugated
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog